While the literature disagrees about the statistical significance of using STEAP1, STEAP2, and STEAP4 for PCa screening, diagnosis, and prognosis, the evidence suggests some degree of clinical utility. The gene discussed is STEAP4; the disease is posterior cortical atrophy.